1062 related articles for article (PubMed ID: 16931473)
1. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
Biskupiak JE; Brixner DI; Howard K; Oderda GM
J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
[TBL] [Abstract][Full Text] [Related]
2. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
Lewis JD; Kimmel SE; Localio AR; Metz DC; Farrar JT; Nessel L; Brensinger C; McGibney K; Strom BL
Gastroenterology; 2005 Dec; 129(6):1865-74. PubMed ID: 16344055
[TBL] [Abstract][Full Text] [Related]
3. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs.
Wilcox CM; Cryer B; Triadafilopoulos G
J Rheumatol; 2005 Nov; 32(11):2218-24. PubMed ID: 16265706
[TBL] [Abstract][Full Text] [Related]
4. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
Thomas J; Straus WL; Bloom BS
Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal tract bleeding associated with naproxen sodium vs ibuprofen.
Strom BL; Schinnar R; Bilker WB; Feldman H; Farrar JT; Carson JL
Arch Intern Med; 1997 Dec 8-22; 157(22):2626-31. PubMed ID: 9531232
[TBL] [Abstract][Full Text] [Related]
6. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug usage and gastrointestinal outcomes in the Republic of Serbia.
Petric M; Tasic L; Sukljevic S
J Pain Palliat Care Pharmacother; 2009; 23(1):40-7. PubMed ID: 19296354
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
10. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
Fries JF; Bruce B
J Rheumatol; 2003 Oct; 30(10):2226-33. PubMed ID: 14528521
[TBL] [Abstract][Full Text] [Related]
11. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
Rahme E; Pettitt D; LeLorier J
Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
[TBL] [Abstract][Full Text] [Related]
12. Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction.
Hudson M; Baron M; Rahme E; Pilote L
J Rheumatol; 2005 Aug; 32(8):1589-93. PubMed ID: 16078339
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
Ray WA; Varas-Lorenzo C; Chung CP; Castellsague J; Murray KT; Stein CM; Daugherty JR; Arbogast PG; García-Rodríguez LA
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
[TBL] [Abstract][Full Text] [Related]
15. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
McCarthy DM
Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
[TBL] [Abstract][Full Text] [Related]
17. Postoperative hemorrhage with nonsteroidal anti-inflammatory drug use after tonsillectomy: a meta-analysis.
Krishna S; Hughes LF; Lin SY
Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1086-9. PubMed ID: 14568792
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
[TBL] [Abstract][Full Text] [Related]
19. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
[TBL] [Abstract][Full Text] [Related]
20. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
